Neonatal calcium, magnesium, and phosphorus disorders

Pediatric Endocrinology, Fifth Edition: Volume 2 Growth, Adrenal, Sexual, Thyroid, Calcium, and Fluid Balance Disorders

Volumn , Issue , 2006, Pages 497-529

  Koo, Winston W K ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84859442462     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (177)

1. Ziegler EE, O’Donnell AM, Nelson SE, et al. Body composition of the reference fetus. Growth 1976; 40:329-341.
2. Koo WWK, Steichen JJ. Osteopenia and rickets of prematurity. In: Polin R, Fox W, eds. Fetal and Neonatal Physiology. 2nd ed. Philadelphia: WB Saunders, 1998: 2335-2349.
3. Murthy JN, Hicks JM, Soldin SJ. Evaluation of i-STAT portable clinical analyzer in a neonatal and pediatric intensive care unit. Clin Biochem 1997; 30:385-389.
4. Dollberg S, Bauer R, Lubetzky R, et al. A reappraisal of neonatal blood chemistry reference ranges using the Nova M electrodes. Am J Perinatol 2001; 18:433-440.
5. Loughead JL, Mimouni F, Tsang RC. Serum ionized calcium concentrations in normal neonates. Am J Dis Child 1988; 142:516-518.
6. Handwerker SM, Altura BT, Jones KY, et al. Maternal-fetal transfer of ionized serum magnesium during the stress of labor and delivery: a human study. J Am Coll Nutr 1995; 14:376-381.
7. Koo B, Sauser K, Hammami M, et al. Neonatal magnesium homeostasis with and without maternal magnesium treatment. Clin Chem 1996; 42:S309.
8. Marcus JC, Valencia GB, Altura BT, et al. Serum ionized magnesium in premature and term infants. Pediatr Neurol 1998; 18:311-314.
9. Sanders GT, Huijgen HJ, Sanders R. Magnesium in disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med 1999; 37:1011-1033.
10. Markowitz M, Rotkin L, Rosen JF. Circadian rhythms of blood minerals in humans. Science 1981; 213: 672-674.
11. Annino JS, Relman AS. The effect of eating on some of the clinically important chemical constituents of blood. Am J Clin Pathol 1959; 31:155-159.
12. Rubin LP, Posillico JT, Anast CS, et al. Circulating levels of biologically active and immunoreactive intact parathyroid hormone in human newborns. Pediatr Res 1991; 29:201-207.
13. Saggese G, Baroncelli GI, Bertelloni S, et al. Intact parathyroid hormone levels during pregnancy, in healthy term neonates and in hypocalcemic preterm infants. Acta Paediatr Scand 1991; 80:36-41.
14. Venkataraman PS, Blick KE, Fry HD, et al. Postnatal changes in calcium-regulating hormones in very-lowbirth-weight infants. Effect of early neonatal hypocalcemia and intravenous calcium infusion on serum parathyroid hormone and calcitonin homeostasis. Am J Dis Child 1985; 139:913-916.
15. Mimouni F, Loughead J, Tsang R, et al. Postnatal surge in serum calcitonin concentrations: no contribution to neonatal hypocalcemia in infants of diabetic mothers. Pediatr Res 1990; 28:493-495.
16. Dilena BA, White GH. The responses of plasma ionised calcium and intact parathyrin to calcium supplementation in preterm infants. Acta Paediatr Scand 1991; 80:1098-1100.
17. Brown EM. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 1983; 56:572-581.
18. Mathias RS, Nguyen HT, Zhang MY, et al. Reduced expression of the renal calcium-sensing receptor in rats with experimental chronic renal insufficiency. J Am Soc Nephrol 1998; 9:2067-2074.
19. Drueke TB. Abnormal skeletal response to parathyroid hormone and the expression of its receptor in chronic uremia. Pediatr Nephrol 1996; 10:348-350.
20. Toffaletti J, Cooper DL, Lobaugh B. The response of parathyroid hormone to specific changes in either ionized calcium, ionized magnesium, or protein-bound calcium in humans. Metabolism 1991; 40:814-818.
21. Zofkova I, Kancheva RL. The relationship between magnesium and calciotropic hormones. Magnes Res 1995; 8:77-84.
22. Fatemi S, Ryzen E, Flores J, et al. Effect of experimental human magnesium depletion on parathyroid hormone secretion and 1,25-dihydroxyvitamin D metabolism. J Clin Endocrinol Metab 1991; 73:1067-1072.
23. Felsenfeld AJ, Rodriguez M. Phosphorus, regulation of plasma calcium, and secondary hyperparathyroidism: a hypothesis to integrate a historical and modern perspective. J Am Soc Nephrol 1999; 10:878-890.
24. Slatopolsky E, Brown A, Dusso A. Role of phosphorus in the pathogenesis of secondary hyperparathyroidism. Am J Kidney Dis 2001; 37:S54-S57.
25. Huwyler R, Born W, Ohnhaus EE, et al. Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man. Am J Physiol 1979; 236:E15-E19.
26. Samaan NA, Anderson GD, Adam-Mayne ME. Immunoreactive calcitonin in the mother, neonate, child and adult. Am J Obstet Gynecol 1975; 121:622-625.
27. Bell NH, Shaw S, Turner RT. Evidence that 1,25-dihydroxyvitamin D3 inhibits the hepatic production of 25-hydroxyvitamin D in man. J Clin Invest 1984; 74:1540-1544.
28. Clements MR, Johnson L, Fraser DR. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 1987; 325:62-65.
29. Robertson WC Jr. Calcium carbonate consumption during pregnancy: an unusual cause of neonatal hypocalcemia. J Child Neurol 2002; 17:853-855.
30. Ravid A, Koren R, Rotem C, et al. Mononuclear cells from human neonates are partially resistant to the action of 1,25 dihydroxyvitamin D. J Clin Endocrinol Metab 1988; 67:755-759.
31. Dincsoy MY, Tsang RC, Laskarzewski P, et al. Serum calcitonin response to administration of calcium in newborn infants during exchange blood transfusion. J Pediatr 1982; 100:782-786.
32. Nelson N, Finnstrom O, Larsson L. Plasma ionized calcium, phosphate and magnesium in preterm and small for gestational age infants. Acta Paediatr Scand 1989; 78:351-357.
33. Shinki T, Jin CH, Nishimura A, et al. Parathyroid hormone inhibits 25 hydroxyvitamin D3-24-hydroxylase mRNA expression stimulated by 1a,25-dihydroxyvitamin D3 in rat kidney but not in intestine. J Biol Chem 1992; 267:13757-13762.
34. Hanukoglu A, Chalen S, Kowardski AA. Late onset hypocalcemia, rickets and hypoparathyroidism in an infant of a mother with hyperparathyroidism. J Pediatr 1988; 112:751-754.
35. Schwartz R, Teramo KA. Effects of diabetic pregnancy on the fetus and newborn. Semin Perinatol 2000; 24:120-135.
36. Specker B, Tsang R, Ho M, et al. Low serum calcium and high parathyroid hormone levels in neonates fed humanized cow’s milk-based formula. Am J Dis Child 1991; 145:941-945.
37. Verity CM, Burman D, Beadle PC, et al. Seasonal changes in perinatal vitamin D metabolism: maternal and cord blood biochemistry in normal pregnancies. Arch Dis Child 1981; 56:943-948.
38. Hollis BW, Pittard WB III. Evaluation of the total fetomaternal vitamin D relationship at term: evidence for racial differences. J Clin Endocrinol Metab 1984; 59:652-657.
39. Nehama H, Weintroub S, Eisenberg Z, et al. Seasonal variation in paired maternal newborn serum 25 hydroxyvitamin D and 24,25 dihydroxyvitamin D concentrations in Israel. Isr J Med Sci 1987; 23:274-277.
40. Adams JS, Sharma OP, Gacad MA, et al. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 1983; 72:1856-1860.
41. Overbergh L, Decallonne B, Valckx D, et al. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 2000; 120:139-146.
42. Martin TJ, Moseley JM, Williams ED. Parathyroid hormone-related protein: hormone and cytokine. J Endocrinol 1997; 154:S23-S37.
43. Bilezikian JP. Clinical utility of assays for parathyroid hormone-related protein. Clin Chem 1992; 38:179-181.
44. Thiebaud D, Janisch S, Koelbl H, et al. Direct evidence of a parathyroid related protein gradient between the mother and the newborn in humans. Bone Miner 1993; 23:213-221.
45. Seki K, Wada S, Nagata N, et al. Parathyroid hormonerelated protein during pregnancy and the perinatal period. Gynecol Obstet Invest 1994; 37:83-86.
46. Salsburey DJ, Brown DR. Effect of parenteral calcium treatment on blood pressure and heart rate in neonatal hypocalcemia. Pediatrics 1982; 69:605-609.
47. Mirro R, Brown DR. Parenteral calcium treatment shortens the left ventricular systolic time intervals of hypocalcemic neonates. Pediatr Res 1984; 18:71-73.
48. Venkataraman PS, Wilson DA, Sheldon RE, et al. Effect of hypocalcemia on cardiac function in very-low-birthweight preterm neonates: studies of blood ionized calcium, echocardiography and cardiac effect of intravenous calcium therapy. Pediatrics 1985; 76:543-550.
49. Broner CW, Stidham GL, Westenkirchner DF, et al. Hypermagnesemia and hypocalcemia as predictors of high mortality in critically ill pediatric patients. Crit Care Med 1990; 18:921-928.
50. Venkataraman PS, Tsang RC, Chen IW, et al. Pathogenesis of early neonatal hypocalcemia: studies of serum calcitonin, gastrin, and plasma glucagon. J Pediatr 1987; 110:599-603.
51. David L, Salle BL, Putet G, et al. Serum immunoreactive calcitonin in low birth weight infants. Description of early changes; effect of intravenous calcium infusion; relationships with early changes in serum calcium, phosphorus, magnesium, parathyroid hormone and gastrin levels. Pediatr Res 1981; 15:803-814.
52. Venkataraman PS, Tsang RC, Steichen JJ, et al. Early neonatal hypocalcemia in extremely preterm infants: high incidence, early onset, and refractoriness to supraphysiologic dose of calcitrol. Am J Dis Child 1986; 140:1004-1008.
53. Koo WWK, Tsang RC, Poser JW, et al. Elevated serum calcium and osteocalcin levels from calcitriol in preterm infants. A prospective randomized study. Am J Dis Child 1986; 140:1152-1158.
54. Thomas AK, McVie R, Levine SN. Disorders of maternal calcium metabolism implicated by abnormal calcium metabolism in the neonate. Am J Perinatol 1999; 16:515-520.
55. Mimouni F, Tsang, RC, Hertzberg VS, et al. Polycythemia, hypomagnesemia and hypocalcemia in infants of diabetic mothers. Am J Dis Child 1986; 140:798-800.
56. Banerjee S, Mimouni FB, Mehta R, et al. Lower whole blood ionized magnesium concentrations in hypocalcemic infants of gestational diabetic mothers. Magnes Res 2003; 16:127-130.
57. Sarkar S, Watman J, Seigel WM, et al. A prospective controlled study of neonatal morbidities in infants born at 36 weeks or more gestation to women with diet-controlled gestational diabetes (GDM-class Al). J Perinatol 2003; 23:223-228.
58. Venkataraman PS, Tsang RC, Greer FR, et al. Late infantile tetany and secondary hyperparathyroidism in infants fed humanized cow milk formula. Longitudinal follow-up. Am J Dis Child 1985; 139:664-668.
59. Perlman JM. Fatal hyperphosphatemia after oral phosphate overdose in a premature infant. Am J Health Syst Pharm 1997; 54:2488-2490.
60. Davis RF, Eichner JM, Bleyuer WA, et al. Hypocalcemia, hyperphosphatemia and dehydration following a single hypertonic phosphate enema. J Pediatr 1977; 90:484-485.
61. Dincsoy MY, Tsang RC, Laskarzewski P, et al. The role of postnatal age and magnesium on parathyroid hormone responses during “exchange” blood transfusion in the newborn period. J Pediatr 1982; 100:277-283.
62. Bainbridge R, Mughal Z, Mimouni F, et al. Transient congenital hypoparathyroidism: how transient is it? J Pediatr 1988; 111:866-868.
63. Kooh SW, Binet A. Partial hypoparathyroidism: a variant of transient congenital hypoparathyroidism. Am J Dis Child 1991; 145:877-880.
64. Greig F, Paul E, DiMartino-Nardi J, et al. Transient congenital hypoparathyroidism: resolution and recurrence in chromosome 22q11 deletion. J Pediatr 1996; 128:563-567.
65. Arnold A, Horst SA, Gardella TJ, et al. Mutation of the signal peptide-encoding region of the preproparathyroid hormone gene in familial isolated hypoparathyroidism. J Clin Invest 1990; 86:1084-1087.
66. Bilous RW, Murty G, Parkinson DB, et al. Autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. N Engl J Med 1992; 327:1069-1074.
67. Sunthornthepvarakul T, Churesigaew S, Ngowngarmratana S. A novel mutation of the signal peptide of the preproparathyroid hormone gene associated with autosomal recessive familial isolated hypoparathyroidism. J Clin Endocrinol Metab 1999; 84:3792-3796.
68. Taylor SC, Morris G, Wilson D, et al. Hypoparathyroidism and 22q11 deletion syndrome. Arch Dis Child 2003; 88:520-522.
69. Swillen A, Devriendt K, Legius E, et al. The behavioural phenotype in velo-cardio-facial syndrome (VCFS): from infancy to adolescence. Genet Couns 1999; 10:79-88.
70. Gerdes M, Solot C, Wang PP, et al. Taking advantage of early diagnosis: preschool children with the 22q11. 2 deletion. Genet Med 2001; 3:40-44.
71. Greenhalgh KL, Aligianis IA, Bromilow G, et al. 22q11 deletion: a multisystem disorder requiring multidisciplinary input. Arch Dis Child 2003; 88:523-524.
72. Keppen LD, Fasules JW, Burks AW, et al. Confirmation of autosomal dominant transmission of the DiGeorge malformation complex. J Pediatr 1988; 113:506-508.
73. Baron J, Winer KK, Yanovski JA, et al. Mutations in the Ca2p-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 1996; 5:601-606.
74. Pearce SH, Williamson C, Kifor O, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium sensing receptor. N Engl J Med 1996; 335:1115-1122.
75. Zhang P, Jobert AS, Couvineau A, et al. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab 1998; 83:3365-3368.
76. Ringel MD, Schwindinger WF, Levine MA. Clinical implications of genetic defects in G proteins: the molecular basis of McCune Albright syndrome and Albright hereditary osteodystrophy. Medicine 1996; 75:171-184.
77. Linglart A, Carel JC, Garabedian M, et al. GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance. J Clin Endocrinol Metab 2002; 87:189-197.
78. Bastepe M, Lane AH, Juppner H. Paternal uniparental isodisomy of chromosome 20q and the resulting changes inGNAS1 methylation as a plausible cause of pseudohypoparathyroidism. Am J Hum Genet 2001; 68:1283-1289.
79. Minagawa M, Yasuda T, Kobayashi Y, et al. Transient pseudohypoparathyroidism of the neonate. Eur J Endocrinol 1995; 133:151-155.
80. Mimouni F, Mimouni CP, Loughead JL, et al. A case control study of hypocalcemia in high risk neonates: racial, but no seasonal differences. J Am Coll Nutr 1991; 10:196-199.
81. Srinivasan M, Abinun M, Cant AJ, et al. Malignant infantile osteopetrosis presenting with neonatal hypocalcemia. Arch Dis Child Fetal Neonatal Ed 2000; 83:F21-F23.
82. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition 2001; 17:632-637.
83. Weinsier RL, Krumdieck CL. Death resulting from overzealous total parenteral nutrition: the refeeding syndrome. Am J Clin Nutr 1980; 34:393-399.
84. Foldenauer A, Vossbeck S, Pohlandt F. Neonatal hypocalcaemia associated with rotavirus diarrhoea. Eur J Pediatr 1998; 157:838-842.
85. Wasant P, Matsumoto I, Naylor E, et al. Mitochondrial fatty acid oxidation disorders in Thai infants: a report of 3 cases. J Med Assoc Thai 2002; 85(suppl 2):S710-S719.
86. Sarici SU, Serdar MA, Erdem G, et al. Evaluation of plasma ionized magnesium levels in neonatal hyperbilirubinemia. Pediatr Res 2004; 55:243-247.
87. Romagnoli C, Polidori G, Cataldi L, et al. Phototherapy induced hypocalcemia. J Pediatr 1979; 94:815-816.
88. Oleske JM. Experience with 118 infants born to narcoticusing mothers: does a lower serum ionized calcium level contribute to the symptoms of withdrawal? Clin Pediatr 1977; 16:418-423.
89. Broner CW, Stidham GL, Westenkirchner DF, et al. A prospective, randomized, double-blind comparison of calcium chloride and calcium gluconate therapies for hypocalcemia in critically ill children. J Pediatr 1990; 117:986-989.
90. Koo WWK, Kaplan LA. Aluminum and bone disorders: with specific reference to aluminumcontamination of infant nutrients. J Am Coll Nutr 1988; 7:199-214.
91. Koo WWK, Antony G, Stevens LH. Continuous nasogastric phosphorus infusion in hypophosphatemic rickets of prematurity. Am J Dis Child 1984; 138:172-175.
92. Koo WWK, Tsang RC, Steichen JJ, et al. Parenteral nutrition for infants: effect of high versus low calcium and phosphorus content. J Pediatr Gastroenterol Nutr 1987; 6:96-104.
93. Koo WWK, Tsang RC, Succop P, et al. Minimal vitamin D and high calcium and phosphorus needs of preterm infants receiving parenteral nutrition. J Pediatr Gastroenterol Nutr 1989; 8:225-233.
94. Lyon AJ, McIntosh N, Wheeler K, et al. Hypercalcemia in extremely low birthweight infants. Arch Dis Child 1984; 59:1141-1144.
95. Kimura S, Nose O, Seino Y, et al. Effects of alternate and simultaneous administrations of calcium and phosphorus on calcium metabolism in children receiving total parenteral nutrition. J Parenteral Enteral Nutr 1986; 10:513-516.
96. Pearce SH, Trump D, Wooding C, et al. Calcium-sensing receptor mutations in familial benign hypercalcaemia and neonatal hyperparathyroidism. J Clin Invest 1995; 96:2683-2692.
97. Wilkinson H, James J. Self limiting neonatal primary hyperparathyroidism associated with familial hypocalciuric hypercalcemia. Arch Dis Child 1993; 69:319-321.
98. Ross AJ, Cooper A, Attie MF, et al. Primary hyperparathyroidism in infancy. J Pediatr Surg 1986; 21:493-499.
99. Pollak M, Chou Y, Marx S, et al. Familial hypocalcuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 1994; 93:1108-1112.
100. Schipani E, Langman C, Parfitt AM, et al. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptides in Jansen’s metaphyseal chondrodysplasia. N Engl J Med 1996; 335:708-714.
101. Loughead J, Mughal F, Mimouni F, et al. Spectrum and natural history of congenital hyperparathyroidism secondary to maternal hypocalcemia. Am J Perinatol 1990; 7:350-355.
102. Savani R, Mimouni F, Tsang R. Maternal and neonatal hyperparathyroidism as a consequence of maternal renal tubular acidosis. Pediatrics 1993; 91:661-663.
103. Rodriguez-Soriano J, Garcia-Fuentes M, Vallo A, et al. Hypercalcemia in neonatal distal renal tubular acidosis. Pediatr Nephrol 2000; 14:354-355.
104. Lakhdir F, Lawson D, Schatz D. Fatal parathyroid hormone-related protein-induced humoral hypercalcemia of malignancy in a 3-month old infant. Eur J Pediatr 1994; 153:718-720.
105. Michigami T, Yamato H, Mushiake S, et al. Hypercalcemia associated with infantile fibrosarcoma producing parathyroid hormone-related protein. J Clin Endocrinol Metab 1996; 81:1090-1095.
106. Mahoney C, Cassady C, Weinberger E, et al. Humoral hypercalcemia due to an occult renal adenoma. Pediatr Nephrol 1997; 11:339-342.
107. Amar AM, Tomlinson G, Green DM, et al. Clinical presentation of rhabdoid tumors of the kidney. J Pediatr Hematol Oncol 2001; 23:105-108.
108. Markestad T, Hesse V, Siebenhuner M, et al. Intermittent high-dose vitamin D prophylaxis during infancy: effect on vitamin D metabolites, calcium, and phosphorus. Am J Clin Nutr 1987; 46:652-658.
109. Hicks MJ, Levy ML, Alexander J, et al. Subcutaneous fat necrosis of the newborn and hypercalcemia: case report and review of the literature. Pediatr Dermatol 1993; 10:271-276.
110. Bush ME, Dahms BB. Fatal hypervitaminosis A in a neonate. Arch Pathol Lab Med 1984; 108:838-842.
111. Tau C, Garabedian M, Farriaux JP, et al. Hypercalcemia in infants with congenital hypothyroidism and its relation to vitamin D and thyroid hormones. J Pediatr 1986; 109:808-814.
112. Telvi L, Pinard J, Ion R, et al. De novo t(X; 21)(q28; q11) in a girl with phenotypic features of Williams-Beuren syndrome. J Med Genet 1992; 29:747-749.
113. Nickerson E, Greenberg F, Keating MT, et al. Deletions of the elastin gene at 7q11.23 occur in 90% of patients with Williams syndrome. Am J Hum Genet 1995; 56:1156-1161.
114. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994; 15:439-461.
115. Strehle EM, Ahmed OA, Hameed M, et al. The 4q-Syndrome. Genet Couns 2001; 12:327-339.
116. Zwischenberger JB, Nguyen TT, Upp JR Jr., et al. Complications of neonatal extracorporeal membrane oxygenation. Collective experience from the Extracorporeal Life Support Organizations. J Thorac Cardiovas Surg 1994; 107:838-848.
117. Fridriksson JH, Helmrath MA, Wessel JJ, et al. Hypercalcemia associated with extracorporeal life support in neonates. J Pediatr Surg 2001; 36:493-497.
118. Rauch F, Plotkin H, Travers R, et al. Osteogenesis imperfecta types I, III, and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab 2003; 88:986-992.
119. Mathias RS. Rickets in an infant with Williams syndrome. Pediatr Nephrol 2000; 14:489-492.
120. Koo WWK, Tsang RC. Calcium and magnesium homeostasis. In: MacDonald MG, Seshia MMK, Mullett MD, eds. Neonatology-Pathophysiology and Management of the Newborn. 5th ed. Philadelphia: Lippincott-Williams and Wilkins, 2005:847-875.
121. Mimouni F, Tsang RC. Perinatal magnesium metabolism: personal data and challenges for the 1990s. Magnes Res 1991; 4:109-117.
122. Monteleone JA, Lee JB, Tashjian AH Jr., et al. Transient neonatal hypocalcemia, hypomagnesemia and high serum parathyroid hormone with maternal hyperparathyroidism. Ann Intern Med 1975; 82:670-672.
123. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002; 31:166-170.
124. Walder RY, Shalev H, Brennan TM, et al. Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet 1997; 6:1491-1497.
125. Weber S, Schneider L, Peters M, et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol 2001; 12:1872-1881.
126. Ghazali S, Hallett RJ, Barratt TM. Hypomagnesemia in uremic infants. J Pediatr 1972; 81:747-750.
127. Bajpai PC, Sugden D, Stern L, et al. Serum ionic magnesium in exchange transfusion. J Pediatr 1967; 70:193-199.
128. Visudhiphan P, Visudtibhan A, Chiemchanya S, et al. Neonatal seizures and familial hypomagnesemia with secondary hypocalcemia. Pediatr Neurol 2005; 33:202-205.
129. Unachak K, Louthrenoo O, Katanyuwong K. Primary hypomagnesemia in Thai infants: a case report with 7 years follow-up and review of literature. J Med Assoc Thai 2002; 85:1226-1231.
130. Stone SR, Pritchard JA. Effect of maternally administered magnesium sulfate on the neonate. Obstet Gynecol 1970; 35:574-577.
131. Lipsitz PJ. The clinical and biochemical effects of excess magnesium in the newborn. Pediatrics 1971; 47:501-509.
132. Koo WWK, Fong T, Gupta JM. Parenteral nutrition in infants. Aust Paediatr J 1980; 16:169-174.
133. Ali A, Walentik C, Mantych GJ, et al. Iatrogenic acute hypermagnesemia after total parenteral nutrition infusion mimicking septic shock syndrome: two case reports. Pediatrics 2003; 112:e70-e72.
134. Cholst IN, Steinberg SF, Tropper PJ, et al. The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects. N Engl J Med 1984; 310:1221-1225.
135. Donovan EF, Tsang RC, Steichen JJ, et al. Neonatal hypermagnesemia: effect on parathyroid hormone and calcium homeostasis. J Pediatr 1980; 96:305-310.
136. Hall RT, Wheeler RE, Rippetoe LE. Calcium and phosphorus supplementation after initial hospital discharge in breast-fed infants of less than 1800 grams birth weight. J Perinatol 1993; 13:272-278.
137. Arnaud SB, Stickler OB, Haworth JC. Serum 25-hydroxyvitamin D in infantile rickets. Pediatrics 1976; 57:221-225.
138. Venkataraman PS, Tsang RC, Buckley DD, et al. Elevation of serum 1,25-dihydroxyvitamin D in response to physiologic doses of vitamin D in vitamin D deficient infants. J Pediatr 1983; 103:416-419.
139. Tenenhouse HS. Cellular and molecular mechanisms of renal phosphate transport. J Bone Miner Res 1997; 12:159-164.
140. Koo WWK. Parenteral nutrition-related bone disease. J Parenteral Enteral Nutr 1992; 16:386-394.
141. Malloy PJ, Feldman D. Hereditary 1,25-dihydroxyvitamin D-resistant rickets. Endocr Dev 2003; 6:175-199.
142. Drezner MK. Hypophosphatemic rickets. Endocr Dev 2003; 6:126-155.
143. Minamitani K, Minagawa M, Yasuda T, et al. Early detection of infants with hypophosphatemic vitamin D resistant rickets (HDRR). Endocr J 1996; 43:339-343.
144. Kruse K, Hinkel GK, Griefahn B. Calcium metabolism and growth during early treatment of children with X-linked hypophosphatemic rickets. Eur J Pediatr 1998; 157:894-900.
145. Pierson JD, Crawford JD. Dietary dependent neonatal hypocalcemia. Am J Dis Child 1972; 123:472-474.
146. Jacobus C, Holick M, Shao Q, et al. Hypervitaminosis D associated with drinking milk. N Engl J Med 1992; 326:1173-1177.
147. Holick M, Shao Q, Liu W, et al. The vitamin D content of fortified milk and infant formula. N Engl J Med 1992; 326:1178-1181.
148. Raiten DJ, Talbot JM, Waters JH (guest editors). Assessment of nutrient requirements for infant formulas: vitamin A. J Nutr 1998; 128(suppl 11S):2182S-2183S.
149. Walton DM, Thomas DC, Aly HZ, et al. Morbid hypocalcemia associated with phosphate enema in a sixweek-old infant. Pediatrics 2000; 106:E37.
150. Laflamme GH, Jowsey J. Bone and soft tissue changes with oral phosphate supplements. J Clin Invest 1972; 51:2834-2840.
151. Steichen JJ, Gratton T, Tsang RC. Osteopenia of prematurity: the cause and possible treatment. J Pediatr 1980; 96:528-534.
152. Nozza JM, Rodda CP. Vitamin D deficiency in mothers of infants with rickets. Med J Aust 2001; 175:253-255.
153. Thacher TD, Fischer PR, Pettifor JM, et al. A comparison of calcium, vitamin D, or both for nutritional rickets in Nigerian children. New Engl J Med 1999; 341:563-568.
154. Koo WWK, Gupta JM, Nayanar VV, et al. Skeletal changes in premature infants. Arch Dis Child 1982; 57:447-452.
155. James JR, Congdon PJ, Truscott J, et al. Osteopenia of prematurity. Arch Dis Child 1986; 61:871-876.
156. Lyon AJ, McIntosh N, Wheeler K, et al. Radiological rickets in extremely low birthweight infants. Pediatr Radiol 1987; 17:56-58.
157. Koo WWK, Massom LR, Walters J. Validation of accuracy and precision of dual energy x-ray absorptiometry for infants. J Bone Miner Res 1995; 10:1111-1115.
158. Koo WWK, Hammami M, Hockman EM. Use of fan beam dual energy X-ray absorptiometry to measure body composition of piglets. J Nutr 2002; 132:1380-1383.
159. Chauhan S, KooWWK, Hammami M, et al. Fan beam dual energy X-ray absorptiometry body composition measurements in piglets. J Am Coll Nutr 2003; 22:408-414.
160. Koo WWK, Hammami M, Hockman EM. Validation of bone mass and body composition measurements in small subjects with pencil beam dual energy X-ray absorptiometry. J Am Coll Nutr 2004; 23:79-84.
161. Koo WWK, Sherman R, Succop P, et al. Fractures and rickets in very low birth weight infants: conservative management and outcome. J Pediatr Orthop 1989; 9:326-330.
162. Koo WWK, Sherman R, Succop P, et al. Serum vitamin D metabolites in very low birth weight infants with and without rickets and fractures. J Pediatr 1989; 114: 1017-1022.
163. KooWWK. Laboratory assessment of nutritional metabolic bone disease in infants. Clin Biochem 1996; 29:429-438.
164. Koo WWK, Succop P, Hambidge KM. Serum alkaline phosphatase and serum zinc concentrations in preterm infants with rickets and fractures. Am J Dis Child 1989; 143:1342-1345.
165. Koo WWK, Succop P, Hambidge KM. Sequential concentrations of copper and ceruloplasmin in serum from preterm infants with rickets and fractures. Clin Chem 1991; 37:556-559.
166. Koo WWK, Warren L. Calcium and bone health in infants. Neonatal Netw 2003; 22:23-37.
167. Koo WWK, McLaughlin K, Saba M. Nutrition support for the neonatal intensive care patients. In: Merritt R, (editorin-chief). The ASPEN Nutrition Support Practice Manual: 2nd ed. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition 2005:301-314.
168. Gartner LM, Greer FR on behalf of Section on Breastfeeding, Committee on Nutrition, American Academy of Pediatrics: Prevention of rickets, vitamin D deficiency: new guidelines for vitamin D intake.
169. Koo WWK, Tsang RC, Steichen JJ, et al. Vitamin D requirement in infants receiving parenteral nutrition. JPEN 1987; 11:172-176.
170. Hack M, Taylor HG, Klein N, et al. School-age outcomes in children with birth weights under 750 g. N Engl J Med 1994; 331:753-759.
171. Hammami M, Picaud JC, Fusch C, et al. Phantoms for cross-calibration of dual energy X-ray absorptiometry measurements in infants. J Am Coll Nutr 2002; 21: 328-332.
172. Koo WWK, Hockman EM, Hammami M. Dual energy X ray absorptiometry measurements in small subjects: conditions affecting clinical measurements. J Am Coll Nutr 2004; 23:212-219.
173. Koo WWK, Hammami M, Shypailo RJ, et al. Bone and body composition measurements of small subjects: discrepancies from software for fan-beam dual energy X-ray absorptiometry. J Am Coll Nutr 2004; 23:647-650.
174. Koo WWK, Walters J, Bush AJ, et al. Dual energy x-ray absorptiometry studies of bone mineral status in newborn infants. J Bone Mineral Res 1996; 11:997-1002.
175. Koo WWK, Bush AJ, Walters J, et al. Postnatal development of bone mineral status during infancy. J Am Coll Nutr 1998; 17:65-70.
176. Hammami M, Koo WWK, Hockman EM. Body composition of neonates from fan beam dual energy Xray absorptiometry measurement. JPEN 2003; 27: 423-426.
177. Koo WWK, Hammami M, Margeson DP, et al. Reduced bone mineralization in infants fed palm olein containing formula: a randomized, double blinded, prospective trial. Pediatrics 2003; 111:1017-1023.